Increased expression of TAZ and associated upregulation of PD-L1 in cervical cancer

被引:0
|
作者
Yanyan Han
Dandan Liu
Lianhong Li
机构
[1] Okayama University Graduate School of Medicine,Department of Pathology
[2] Dentistry,undefined
[3] and Pharmaceutical Sciences,undefined
[4] The Fourth Medical Center of The General Hospital of the Chinese People’s Liberation Army,undefined
[5] Pathology Department of Dalian Medical University,undefined
来源
关键词
TAZ; PD-L1; Cervical cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Increased expression of TAZ and associated upregulation of PD-L1 in cervical cancer
    Han, Yanyan
    Liu, Dandan
    Li, Lianhong
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [2] The comprehensive analysis of PD-L1 expression in cervical cancer
    Jiang, W.
    Yang, H.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 178 - 179
  • [3] Expression profile associated with CD274 (PD-L1) expression in cervical cancer.
    Bassaure, Edgar Roman
    Campos, Jaime Berumen
    Medina, Ingrid Yasbeth
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] Programmed Death Ligand 1 (PD-L1) Expression in Cervical Cancer
    Lathika, Aryakrishna S.
    Lakshmi, S.
    Ramdas, Preethi T.
    Kumar, Aswin
    Mathews, Susan
    Joseph, John
    Mathew, Aleyamma
    James, Francis V.
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 19 (04)
  • [5] Programmed Death Ligand 1 (PD-L1) Expression in Cervical Cancer
    Aryakrishna S. Lathika
    S. Lakshmi
    Preethi T. Ramdas
    Aswin Kumar
    Susan Mathews
    John Joseph
    Aleyamma Mathew
    Francis V. James
    Indian Journal of Gynecologic Oncology, 2021, 19
  • [6] Cancer-Associated Fibroblasts Promote the Upregulation of PD-L1 Expression Through Akt Phosphorylation in Colorectal Cancer
    Gao, Yang
    Sun, Zhao
    Gu, Junjie
    Li, Zhe
    Xu, Xiuxiu
    Xue, Chunling
    Li, Xuechun
    Zhao, Lin
    Zhou, Jianfeng
    Bai, Chunmei
    Han, Qin
    Zhao, Robert Chunhua
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [7] PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential
    Rotman, Jossie
    Otter, Leontine A. S. den
    Bleeker, Maaike C. G.
    Samuels, Sanne S.
    Heeren, A. Marijne
    Roemer, Margaretha G. M.
    Kenter, Gemma G.
    Zijlmans, Henry J. M. A. A.
    van Trommel, Nienke E.
    de Gruijl, Tanja D.
    Jordanova, Ekaterina S.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [8] PD-1/PD-L1 Inhibitors in Cervical Cancer
    Liu, Yuncong
    Wu, Li
    Tong, Ruizhan
    Yang, Feiyue
    Yin, Limei
    Li, Mengqian
    You, Liting
    Xue, Jianxin
    Lu, You
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [9] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [10] The expression and clinical significance of costimulatory molecule PD-L1 on cervical cancer
    Gu, Y.
    Zhang, L.
    Li, X.
    Hu, M.
    Zhang, X.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1751 - 1751